Clinical carecharacteristics and factors associated with in-hospital mortality for lung cancer in Spain;Original características clinicoasistenciales y factores asociados a la mortalidad intrahospitalaria por cáncer de pulmón en España

Medicina Clinica

Volumn 133, Issue 1, 2009, Pages 8-16

  Sendra Gutiérrez, Juan Manuel ^a   Palma Ruiz, Matilde ^a   Martín Martínez, M Auxiliadora ^a   Sarría Santamera, Antonio ^a,b  

^a Instituto de Salud Carlos III ^*  (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Databases as topic; Health services; Hospital mortality; Lung neoplasms; Multivariate analysis

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURGERY; CIGARETTE SMOKING; DESCRIPTIVE RESEARCH; FEMALE; GEOGRAPHY; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING HABIT; SPAIN; LUNG TUMOR; MIDDLE AGED; MORTALITY;

AGED; FEMALE; HOSPITAL MORTALITY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SPAIN;

EID: 67650071014     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.11.035     Document Type: Article

References (31)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24:2137-50.
2. WHO Regional Office for Europe. European detailed mortality database (DMDB). Copenhagen, 2007. [Accedido 12 Feb. 2008.] Disponible en: http://www.euro.who.int/InformationSources/Data/20070615-2
3. Instituto Nacional de Estadística. Inebase. Defunciones según la causa de muerte 2004-2005. [Accedido 20 Feb. 2008.] Disponible en: http://www.ine.es/inebmenu/mnu-salud.htm
4. Ruiz-Ramos M, Expósito-Hernández J. Tendencias de la mortalidad por cáncer en Andalucía entre 1975 y 2003. Med Clin (Barc). 2007;128:448-52.
5. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continentsIARC Scientific Publications IX (160). Lyon: International Agency for Research on Cancer; 2007.
6. Ló pez-Abente G, Pollán M, Aragonés N, Pérez B, Hernández V, Lope V, et al. Situación del cáncer en España: incidencia. An Sist Sanit Navar. 2004;27: 165-73.
7. National Cancer Institute. SEER Cancer Statistics Review 1975-2004. 2007. [Accedido 14 Feb. 2008.] Disponible en: http://seer.cancer.gov/cgi-bin/csr/ 1975-2004/search.pl#results
8. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9 administrative databases. J Clin Epidemiol. 1992;45:613-9.
9. Instituto Nacional de Estadística. Inebase. Encuestas de morbilidad hospitalaria 1997-2005. [Accedido 21 Feb. 2008.] Disponible en: http://www.ine.es/inebmenu/mnu-salud.htm
10. Bosetti C, Levi F, Lucchini F, Negri E, La Vechchia C. Lung cancer mortality in European women: recent trends and perspectives. Ann Oncol. 2005;16: 1597-604.
11. Levi F, Bosetti C, Fernandez E, Hill C, Lucchini F, Negri E, et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer. 2007;121:462-5.
12. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer. 2004;40:96-125.
13. Barnes DJ. The changing face of lung cancer. Chest. 2004;126:1718-21.
14. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest. 2005;128:370-81.
15. Au JS, Mang OW, Foo W, Law SC. Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983-2000. Lung Cancer. 2004;45:143-52.
16. Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer. 2003;105:101-7.
17. Santos - Martínez MJ, Curull V, Blanco ML, Macià F, Mojal S, Vila J, Broquetas JM. [Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series]. Arch Bronconeumol. 2005;41:307-12.
18. Visbal AL, Williams BA, Nichols 3rd FC, Marks RS, Jett JR, Aubry MC, et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4, 618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004;78:209-15.
19. Sánchez I, Izquierdo JL, Almonacid C. Situació n epidemioló gica y pronó stica del cáncer de pulmón en nuestro medio. Arch Bronconeumol. 2006;42:594-9.
20. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57:253-60.
21. Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer. 2007;55:15-23.
22. Lövgren M, Tishelman C, Sprangers M, Koyi H, Hamberg K. Symptoms and problems with functioning among women and men with inoperable lung cancer-A longitudinal study. Lung Cancer. 2008;60:113-24.
23. Fu JB, Kau TY, Severson RK, Kalemkerian GP. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest. 2005;127:768-77.
24. Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest. 2007;132:185-92.
25. Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007;25:5570-7.
26. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004;126:347-51.
27. Simunovic M, Rempel E, Thériault ME, Coates A, Whelan T, Holowaty E, et al. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg. 2006;49: 251-8.
28. Minami H, Yoshimura M, Miyamoto Y, Matsuoka H, Tsubota N. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest. 2000;118:1603-9.
29. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol. 2004;57: 597-609.
30. Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, National Cancer Institute of Canada Clinical Trials Group, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol. 2008;26:54-9.
31. López-Abente G; Ramis R, Pollán M, Aragonés N, Pérez-Gómez B, Gómez-Barroso D, et al. Atlas municipal de mortalidad por cáncer en España, 1989-1998. Instituto de Salud Carlos III. Madrid, 2006.